Scientific coordinator:

Key People:
REBAIOLI LARA

Partners:
Università degli Studi di Brescia
Università degli Studi di Bergamo
Politecnico di Milano

Type: PRIN 2022

End date: 2025

Start date: 2023

Duration: 24

Overall budget: 259.834 €

Funding: 193.176 €

CNR cost: 70.413 €

CNR funding: 48.149 €

STIIMA budget: 70.413 €

STIIMA funding: 48.149 €

Coordinator: Università degli Studi di Brescia

Micro-manufacturing technologies for structured organ-on-chip

Advancement in biomedical research and drug discovery is today importantly limited by the high costs and ethical constraints of in vivo animal studies, as well as by the high cost and duration of clinical trials. Organ-on-a-Chip (OoC) technologies have been recently proposed as valid alternative to investigate pathophysiological processes in vitro using mammalian cells and customized devices. Conventional OoC systems are typically designed and fabricated at laboratory level and assembled in units with complex manipulations. To make OoC technology readily available for high-throughput biological investigations, it is of crucial importance to develop robust manufacturing approaches for tailorable and sustainable production at affordable costs.

The main objective of the MITO project is to design and develop an efficient micromanufacturing process chain for the production of an innovative microfluidic Organ-on-a-Chip (OoC) platform, a structured system for in vitro co-culture and perfusion of mammalian cells. The general aim is to develop efficient, structured, ready to use and expandible systems for culturing cells in conditions that resemble the microphysiological environment, to reproduce cell functions that are notpresent in conventional cell culture systems.

Financed by European Union – NextGenerationEU, Missione 4 Componente 1 (CUP D53D23003370006).

banner